Martek Biosciences---- future biotech cash cow! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nelli who wrote (48)	3/29/1997 12:22:00 PM
From: bill small	of 258

Wu, Had not seen Reuters wire, buy I attended the meeting myself. Really helped me get a scientific dose full of the DHA/ARA issue by listening to the PHDs from around the world discuss the issue. Martek speaker was Dr. Kyle, head of Martek R&D, who spoke of all the studies which supported use of DHA/ARA for infant development. Another strong supporter not mentioned in Reuters article was a researcher from NIH who said in effect the panel would be derelict if they didn't recommend inclusion of DHA/ARA in formula. I think there is ample evidence for formula companies to move ahead, but I wish the Ross people were more muted on the issue. While Martek says (not in public statements) that Ross opposition is really an economic one, I only heard them give technical statements in their testimony. Obviously if the real reason is economic, they couldn't come out and say so. If real reason is economic, the speakers from Ross have technically prostituted themselves in their objections.. best regards Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next